Our growth targets are rooted in leveraging anonymised data to develop proprietary indices representing component data of diagnosis and treatments, claim volume, treatment costs, and other critical healthcare trends.
This approach empowers us to offer curated products that mitigate risks linked to cost or volume fluctuations, paving the way for price discovery and a whole new asset class for investors.
The research arm of our exchange is powered by producing advanced insights into historical, seasonal, and current healthcare trends with flexible and granular data precision.